Martha Rosenberg, AlterNet. June 24, 2008. A new menopause drug is on the market. But don't expect women and physicians to be the easy customers they were back in the Premarin days.
Martha Rosenberg, AlterNet. March 16, 2008. Juries and medical journals are making hormone replacement therapy-mongering increasingly difficult for drug giant Wyeth.
Martha Rosenberg, AlterNet. February 26, 2008. Selling a product that causes cancer isn't easy, but with help from a U.S. endocrinologist group, Wyeth is again obscuring the truth about HRT.
